首页> 美国政府科技报告 >Monoclonal antibody (SZ-51) specific for activated platelets is useful in the diagnosis of thrombosis. Final report for the period December 1990 - April 1994
【24h】

Monoclonal antibody (SZ-51) specific for activated platelets is useful in the diagnosis of thrombosis. Final report for the period December 1990 - April 1994

机译:对活化血小板特异的单克隆抗体(sZ-51)可用于血栓形成的诊断。 1990年12月至1994年4月期间的最后报告

获取原文

摘要

Non invasive detection and localisation of thrombogenesis in various clinical disorders remains a challenge. Mr. C. Ruan and his co-workers from the Jiangsu Institute of Hematology, Thrombosis and Hemostasis Research Unit, Suzhon Medical College, Suzhon, China, had successfully developed the entire steps from the production, purification and radiolabelling of a monoclonal antibody to an alpha granule protein expressed on the surface of activated platelets, to the validation of its immunoreactivity with activated platelets in few clinical disorders characterised by injury to platelets. Further, they have labelled this monoclonal antibody with 99mTc and demonstrated in vivo localisation of thrombogenic foli by an experimental model in dogs using immunoscintigraphic techniques. Biodistribution studies had clearly shown significant labelled antibody accumulation in thrombogenic foli compared to the surrounding blood and soft tissue background. Radiolabelled monoclonal antibody scintigraphy is thus shown to have potential in achieving the hitherto elusive goal of non invasive localisation of thrombogenesis in clinical practice. (Atomindex citation 26:015865)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号